Joe Cohen

发表

Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.

Inácio Mandomando, Marie-Claude Dubois, Quique Bassat, 2009, The Journal of infectious diseases.

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.

Marie-Claude Dubois, Janet Wittes, J. Wittes, 2007, Vaccine.

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.

V. A. Stewart, Janet Wittes, J. Wittes, 2007, Vaccine.

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research.

M. Demoitié, W. Ballou, Joe D. Cohen, 2008, Vaccine.

Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ1

W. Ripley Ballou, Joe D. Cohen, W. Ballou, 2003, The Journal of Immunology.

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

V. A. Stewart, W. Ripley Ballou, Janet Wittes, 2009, PloS one.

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

Inacio Mandomando, Bart Spiessens, Mateu Espasa, 2004, The Lancet.

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Pedro Alonso, Trudie Lang, Bernhards Ogutu, 2011, The New England journal of medicine.

The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.

Pierre Vandepapelière, François Spertini, Erik Jongert, 2013, Tuberculosis.

School-Wide Behavioral Support: Starting the Year Off Right

Robert H. Horner, George Sugai, Joe D. Cohen, 1997 .

Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine.

Zhining Wang, Zhining Wang, Joe D. Cohen, 2010, The Journal of infectious diseases.